Who Paid My Doc
POCC in NASH
Research payments
$18,956,441
Through program year 2025, $18,956,441 in research payments was reported against POCC in NASH, across 1,428 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim RCV GmbH & Co KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,050 | 1 |
| 2024 | Research | $1,624,895 | 50 |
| 2023 | Research | $6,214,960 | 74 |
| 2022 | Research | $9,254,992 | 105 |
| 2021 | Research | $1,859,544 | 1,198 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Guy Neff Sarasota, FL Named on 88 payments
- Rashmee Patil McAllen, TX Named on 37 payments
- Bhaktasharan Patel Colorado Springs, CO Named on 35 payments
- Yaneicy Gonzalez Rojas Coral Gables, FL Named on 34 payments
- Robert Jenders Washington, DC Named on 33 payments
- Stanley Hsia Los Angeles, CA Named on 33 payments
- Mirel Sanchez Miami, FL Named on 33 payments
- Stephen Farrow Biloxi, MS Named on 32 payments
- Eric Lawitz San Antonio, TX Named on 31 payments
- Gary Reiss Marrero, LA Named on 31 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.